Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Keros Therapeutics Inc (KROS)
Keros Therapeutics Inc (KROS) Financials

KROS Keros Therapeutics Inc

58.62

0.00 (0.00%)

Pre Market

Last Updated: 04:00:00

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-9.74	-64.305	-32.355	-22.392	-37.25	-45.21
Return on Equity (%)	37.171	92.651	-37.446	-23.27	-40.215	-50.191
Return on Invested Capital (%)	-31.789	-167.176	-35.487	-23.197	-44.514	-56.372
Operating Margin (%)	-10.78	-123.28	N/A	-282.234	N/A	-101319.205
Net Profit Margin (%)	-13.35	-123.36	N/A	-292.259	N/A	-101319.205
Book Value Per Share	5.685	0.204	11.284	10.143	10.072	11.089
Earnings Per Share	-0.595	-5.077	-1.956	-2.45	-3.801	-5.107
Cash Per Share	10.365	2.889	11.464	9.595	10.131	11.053
Working Capital Per Share	6.266	1.828	11.234	9.993	9.775	10.779
Operating Profit Per Share	4.456	4.115	N/A	0.838	N/A	0.005
EBIT Per Share	-0.48	-5.077	-1.963	-2.366	-3.801	-5.107
EBITDA Per Share	-0.48	-5.077	-1.963	-2.366	-3.801	-5.107
Free Cash Flow Per Share	-0.566	-5.051	-1.955	-2.423	-3.781	-5.052

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	2.226	1.99	37.267	21.226	17.27	14.249
Quick Ratio	2.028	1.565	37.009	20.939	16.864	13.592
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	2.24M	2.43M	23.19M	23.98M	27.54M	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	23.98M	24M	24.43M	26.08M	27.54M	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	19.851	N/A	N/A	N/A	23.433	N/A	N/A
Quick Ratio	N/A	19.624	N/A	N/A	N/A	22.734	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.11B
Price to Earnings Ratio	-13.79
Price to Sales Ratio	13.96k
Price to Cash Ratio	6.37
Price to Book Ratio	6.35
Dividend Yield	-

Share Statistics

Shares Outstanding	35.98M
Average Volume (1 week)	310.96k
Average Volume (1 Month)	270.94k
52 Week Change	32.71%
52 Week High	73.00
52 Week Low	27.02

More Ratios Coming Soon!

Keros Therapeutics

Delayed Upgrade Clock